Viewing Study NCT06747169


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-01-24 @ 3:14 PM
Study NCT ID: NCT06747169
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-27
First Post: 2024-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study
Sponsor: Jian-Guo Zhou, MD, PhD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Non-Small Cell Lung Cancer SqNSCLC View
Keywords: